Viewing Study NCT01425294


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-12 @ 10:43 AM
Study NCT ID: NCT01425294
Status: TERMINATED
Last Update Posted: 2017-12-05
First Post: 2011-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chinese post-menopausal women View
None oestrogen receptor-positive locally advanced View
None metastatic breast cancer View
None fulvestrant 250 mg View
None failure to adjuvant anti-oestrogen therapy View